Analyst Viewpoint
Increase in demand for diagnostics is driving the global ELISA analyzers market. ELISA analyzers measure specific antibodies, antigens, or biomarkers present in patient samples and provide valuable diagnostic information. Integration of cutting-edge technologies, such as automation and artificial intelligence, to improve the efficacy and precision of ELISA assays, is propelling market development. Furthermore, technological advancements in ELISA analyzers are expected to bolster the global ELISA analyzers industry size during the forecast period.
Biomarker discovery and development of personalized medicine offer lucrative opportunities to market players. Manufacturers of diagnostic reagents and instrument suppliers are collaborating to provide integrated solutions that simplify ELISA procedures and provide end-users extensive diagnostic capabilities.
ELISA analyzers are laboratory instruments used for performing enzyme-linked immunosorbent assays (ELISAs), a widely utilized technique for detecting and quantifying specific substances in biological samples.
ELISA analyzers are used in clinical laboratories for the detection of infectious diseases, autoimmune disorders, hormonal imbalances, and various other medical conditions. By measuring specific antibodies, antigens, or biomarkers present in patient samples, ELISAs can provide valuable diagnostic information.
ELISA analyzers play a crucial role in pharmaceutical research and development. These are employed in target identification and validation, screening of potential drug candidates, quantification of drug levels in biological samples, and assessment of immune responses to new therapies.
In addition, ELISAs are utilized to detect and measure tumor markers or specific proteins associated with different types of cancer. These analyzers aid in cancer diagnosis, prognosis, and monitoring of treatment efficacy.
Surge in demand for diagnostics, particularly within the healthcare industry, significantly influences the growth and adoption of ELISA analyzers in the market. Several factors contribute to the increased need for accurate and efficient diagnostic tools such as ELISA analyzers.
Rise in prevalence of a wide spectrum of diseases, including infectious diseases, autoimmune disorders, cancer, and metabolic conditions worldwide is driving demand for diagnostics. As healthcare awareness and access to medical services improve, more individuals seek early disease detection, precise monitoring, and effective management.
Aging global population and increase in incidence of chronic illnesses are fueling demand for diagnostics. ELISA analyzers offer a versatile platform capable of conducting a diverse array of tests, providing clinicians and researchers with critical insights into patient health, facilitating timely treatment decisions, and contributing to improved patient outcomes.
In terms of product type, the automated ELISA analyzers segment accounted for the largest global ELISA analyzers market share in 2022. ELISA is a widely used laboratory technique for detecting and quantifying substances such as proteins, peptides, antibodies, and hormones in biological samples.
Automated ELISA analyzers are advanced systems that automate the ELISA process, offering increased efficiency, accuracy, and throughput compared to manual ELISA procedures. These analyzers consist of a combination of instruments, including robotic sample handling, liquid handling systems, plate washers, incubators, detectors, and software for data analysis.
Automated ELISA analyzers can process a large number of samples simultaneously, reducing the time required for analysis and increasing laboratory productivity. Automated ELISA analyzers offer standardized protocols, ensuring consistent performance across different laboratories and reducing inter-operator variability.
Based on application, the drug development segment dominated the global ELISA analyzers market in 2022. The trend is expected to continue during the forecast period. ELISA analyzers are widely used in various fields, including clinical diagnostics, research laboratories, pharmaceuticals, and food testing.
ELISA analyzers are commonly utilized in drug development, especially in pharmaceutical and biotechnology companies. ELISA is used in drug development for screening and quantifying biomarkers, validating drug candidates, and assessing immune responses.
ELISA analyzers are utilized to measure drug levels in biological samples, such as blood or plasma, to assess PK parameters. ELISA assays can quantify drug concentrations over time, aiding in determining factors such as absorption, distribution, metabolism, and excretion. Additionally, ELISAs can measure biomarkers associated with drug efficacy (PD markers) to evaluate the drug's impact on the target.
In terms of end-user, the pharmaceutical & biotechnology companies segment accounted for significant share of the global ELISA analyzers market in 2022. ELISA is widely used by these companies for various applications, including drug development, quality control, and research.
ELISA is commonly used to detect and quantify specific proteins, antibodies, and other biomolecules crucial in drug discovery and development processes. In addition, identifying and quantifying biomarkers is essential in understanding disease mechanisms and developing targeted therapies, making ELISA a valuable tool in these efforts.
As per ELISA analyzers industry analysis, North America dominated the global industry in 2022. The U.S. and Canada are major players in the ELISA analyzers market, driven by a well-established healthcare system, significant R&D activities, and high prevalence of chronic diseases. Presence of key players and advanced technologies contribute to the growth of the market in the region.
Countries in Europe, including the U.K., Germany, and France, have robust healthcare infrastructure and strong emphasis on research & development. Increase in focus on personalized medicine and biomarker research supports demand for ELISA analyzers in the region.
Increase in investment in healthcare infrastructure, growing biotechnology sector, and rise in healthcare awareness contribute to the growth of the ELISA analyzers market in Asia Pacific.
Leading players are focusing on strategies such as new product launches, mergers, partnerships, and collaborations to strengthen their positions. These companies are following the latest ELISA analyzers market trends to avail lucrative revenue opportunities.
Bio-Rad Laboratories, Inc., Merck KGaA, Thermo Fisher Scientific, Dynex Technologies, Inc., Grifols, S.A., Tecan Group Ltd., Monobind, Transasia Bio-Medicals, MeCan Medical Equipment, and CTK Biotech are the prominent players in the global market.
Prominent players have been profiled in the ELISA analyzers market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and latest developments.
| Attribute | Detail |
|---|---|
| Size in 2022 | US$ 574.7 Mn |
| Forecast (Value) in 2031 | More than US$ 960.7 Mn |
| Growth Rate (CAGR) | 5.9% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Mn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
| Competition Landscape | Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials. |
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 574.7 Mn in 2022.
It is projected to reach more than US$ 960.7 Mn by 2031.
The CAGR is anticipated to be 5.9% from 2023 to 2031.
Technological advancements in ELISA analyzers and increase in demand for diagnostics.
The automated ELISA analyzers product type segment accounted for major share in 2022.
North America is expected to account for major share during the forecast period.
Bio-Rad Laboratories, Inc., Merck KGaA, Thermo Fisher Scientific, Dynex Technologies, Inc., Grifols, S.A., Tecan Group Ltd., Monobind, Transasia Bio-Medicals, MeCan Medical Equipment and CTK Biotech.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global ELISA Analyzers Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Global ELISA Analyzers Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pricing Analysis
5.2. Regulatory Scenario by Region/globally
5.3. COVID-19 Impact Analysis
6. Global ELISA Analyzers Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Automated ELISA Analyzers
6.3.2. Semi-automated ELISA Analyzers
6.4. Market Attractiveness Analysis, by Product Type
7. Global ELISA Analyzers Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Drug Development
7.3.2. Clinical Diagnosis
7.3.3. Others
7.4. Market Attractiveness Analysis, by Application
8. Global ELISA Analyzers Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Diagnostic Laboratories
8.3.2. Pharmaceutical & Biotechnology Companies
8.3.3. Contract Research Organizations
8.3.4. Others
9. Global ELISA Analyzers Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America ELISA Analyzers Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Automated ELISA Analyzers
10.2.2. Semi-automated ELISA Analyzers
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Drug Development
10.3.2. Clinical Diagnosis
10.3.3. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Diagnostic Laboratories
10.4.2. Pharmaceutical & Biotechnology Companies
10.4.3. Contract Research Organizations
10.4.4. Others
10.5. Market Attractiveness Analysis
10.5.1. By Product Type
10.5.2. By Application
10.5.3. By End-user
10.5.4. By Country
11. Europe ELISA Analyzers Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Automated ELISA Analyzers
11.2.2. Semi-automated ELISA Analyzers
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Drug Development
11.3.2. Clinical Diagnosis
11.3.3. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Diagnostic Laboratories
11.4.2. Pharmaceutical & Biotechnology Companies
11.4.3. Contract Research Organizations
11.4.4. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific ELISA Analyzers Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Automated ELISA Analyzers
12.2.2. Semi-automated ELISA Analyzers
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Drug Development
12.3.2. Clinical Diagnosis
12.3.3. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Diagnostic Laboratories
12.4.2. Pharmaceutical & Biotechnology Companies
12.4.3. Contract Research Organizations
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America ELISA Analyzers Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Automated ELISA Analyzers
13.2.2. Semi-automated ELISA Analyzers
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Drug Development
13.3.2. Clinical Diagnosis
13.3.3. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Diagnostic Laboratories
13.4.2. Pharmaceutical & Biotechnology Companies
13.4.3. Contract Research Organizations
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa ELISA Analyzers Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Automated ELISA Analyzers
14.2.2. Semi-automated ELISA Analyzers
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Drug Development
14.3.2. Clinical Diagnosis
14.3.3. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Diagnostic Laboratories
14.4.2. Pharmaceutical & Biotechnology Companies
14.4.3. Contract Research Organizations
14.4.4. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Global ELISA Analyzers Market, Company Share Analysis (2022)
15.2. Company Profiles
15.2.1. Bio-Rad Laboratories, Inc.
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Product Portfolio
15.2.1.3. Financial Overview
15.2.1.4. SWOT Analysis
15.2.1.5. Strategic Overview
15.2.2. Merck KGaA
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Product Portfolio
15.2.2.3. Financial Overview
15.2.2.4. SWOT Analysis
15.2.2.5. Strategic Overview
15.2.3. Thermo Fisher Scientific
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Product Portfolio
15.2.3.3. Financial Overview
15.2.3.4. SWOT Analysis
15.2.3.5. Strategic Overview
15.2.4. Dynex Technologies, Inc.
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Product Portfolio
15.2.4.3. Financial Overview
15.2.4.4. SWOT Analysis
15.2.4.5. Strategic Overview
15.2.5. Grifols, S.A.
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Product Portfolio
15.2.5.3. Financial Overview
15.2.5.4. SWOT Analysis
15.2.5.5. Strategic Overview
15.2.6. Tecan Group Ltd.
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Product Portfolio
15.2.6.3. Financial Overview
15.2.6.4. SWOT Analysis
15.2.6.5. Strategic Overview
15.2.7. Monobind
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Product Portfolio
15.2.7.3. Financial Overview
15.2.7.4. SWOT Analysis
15.2.7.5. Strategic Overview
15.2.8. Transasia Bio-Medicals
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Product Portfolio
15.2.8.3. Financial Overview
15.2.8.4. SWOT Analysis
15.2.8.5. Strategic Overview
15.2.9. MeCan Medical Equipment
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Product Portfolio
15.2.9.3. Financial Overview
15.2.9.4. SWOT Analysis
15.2.9.5. Strategic Overview
15.2.10. CTK Biotech
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Product Portfolio
15.2.10.3. Financial Overview
15.2.10.4. SWOT Analysis
15.2.10.5. Strategic Overview
List of Tables
Table 01: Global ELISA Analyzers Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 02: Global ELISA Analyzers Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 03: Global ELISA Analyzers Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 04: Global ELISA Analyzers Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 05: North America ELISA Analyzers Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 06: North America ELISA Analyzers Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 07: North America ELISA Analyzers Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 08: North America ELISA Analyzers Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 09: Europe ELISA Analyzers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 10: Europe ELISA Analyzers Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 11: Europe ELISA Analyzers Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 12: Europe ELISA Analyzers Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 13: Asia Pacific ELISA Analyzers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 14: Asia Pacific ELISA Analyzers Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 15: Asia Pacific ELISA Analyzers Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 16: Asia Pacific ELISA Analyzers Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 17: Latin America ELISA Analyzers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 18: Latin America ELISA Analyzers Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 19: Latin America ELISA Analyzers Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 20: Latin America ELISA Analyzers Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 21: Middle East & Africa ELISA Analyzers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 22: Middle East & Africa ELISA Analyzers Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 23: Middle East & Africa ELISA Analyzers Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 24: Middle East & Africa ELISA Analyzers Market Value (US$ Mn) Forecast, by End-user, 2017-2031
List of Figures
Figure 01: Global ELISA Analyzers Market Value (US$ Mn) Forecast, 2017-2031
Figure 02: Global ELISA Analyzers Market Value Share, by Region, 2022
Figure 03: Global ELISA Analyzers Market Value Share, by Product Type, 2022
Figure 04: Global ELISA Analyzers Market Value Share, by Application, 2022
Figure 05: Global ELISA Analyzers Market Value Share, by End-user, 2022
Figure 06: Global ELISA Analyzers Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 07: Global ELISA Analyzers Market Value Share Analysis, by Product Type, 2022
Figure 08: Global ELISA Analyzers Market Value Share Analysis, by Product Type, 2031
Figure 09: Global ELISA Analyzers Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 10: Global ELISA Analyzers Market Value (US$ Mn), by Automated ELISA Analyzers, 2017‒2031
Figure 11: Global ELISA Analyzers Market Value Share Analysis, by Automated ELISA Analyzers, 2022 and 2031
Figure 12: Global ELISA Analyzers Market Value (US$ Mn), by Semi-automated ELISA Analyzers, 2017‒2031
Figure 13: Global ELISA Analyzers Market Value Share Analysis, by Semi-automated ELISA Analyzers, 2022 and 2031
Figure 14: Global ELISA Analyzers Market Value Share Analysis, by Application, 2022 and 2031
Figure 15: Global ELISA Analyzers Market Value Share Analysis, by Application, 2022
Figure 16: Global ELISA Analyzers Market Value Analysis, by Application, 2031
Figure 17: Global ELISA Analyzers Market Attractiveness Analysis, by Application, 2023–2031
Figure 18: Global ELISA Analyzers Market Value (US$ Mn), by Drug Development, 2017‒2031
Figure 19: Global ELISA Analyzers Market Value Share Analysis, by Drug Development, 2022 and 2031
Figure 20: Global ELISA Analyzers Market Value (US$ Mn), by Clinical Diagnosis, 2017‒2031
Figure 21: Global ELISA Analyzers Market Value Share Analysis, by Clinical Diagnosis, 2022 and 2031
Figure 22: Global ELISA Analyzers Market Value (US$ Mn), by Others, 2017‒2031
Figure 23: Global ELISA Analyzers Market Value Share Analysis, by Others, 2022 and 2031
Figure 24: Global ELISA Analyzers Market Value Share Analysis, by End-user, 2022 and 2031
Figure 25: Global ELISA Analyzers Market Value Share Analysis, by End-user, 2022
Figure 26: Global ELISA Analyzers Market Value Share Analysis, by End-user, 2031
Figure 27: Global ELISA Analyzers Market Attractiveness Analysis, by End-user, 2023–2031
Figure 28: Global ELISA Analyzers Market Value (US$ Mn), by Diagnostic Laboratories, 2017‒2031
Figure 29: Global ELISA Analyzers Market Value Share Analysis, by Diagnostic Laboratories, 2022 and 2031
Figure 30: Global ELISA Analyzers Market Value (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2017‒2031
Figure 31: Global ELISA Analyzers Market Value Share Analysis, by Pharmaceutical & Biotechnology Companies, 2022 and 2031
Figure 32: Global ELISA Analyzers Market Value (US$ Mn), by Contract Research Organizations, 2017‒2031
Figure 33: Global ELISA Analyzers Market Value Share Analysis, by Contract Research Organizations, 2022 and 2031
Figure 34: Global ELISA Analyzers Market Value (US$ Mn), by Others, 2017‒2031
Figure 35: Global ELISA Analyzers Market Value Share Analysis, by Others, 2022 and 2031
Figure 36: Global ELISA Analyzers Market Value Share Analysis, by Region, 2022 and 2031
Figure 37: Global ELISA Analyzers Market Value Share Analysis, by Region, 2022
Figure 38: Global ELISA Analyzers Market Value Analysis, by Region, 2031
Figure 39: Global ELISA Analyzers Market Attractiveness Analysis, by Region, 2023–2031
Figure 40: North America ELISA Analyzers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 41: North America ELISA Analyzers Market Value Share Analysis, by Country, 2022 and 2031
Figure 42: North America ELISA Analyzers Market Attractiveness Analysis, by Country, 2023–2031
Figure 43: North America ELISA Analyzers Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
Figure 44: North America ELISA Analyzers Market Value (US$ Mn) Share Analysis, by Product Type, 2022
Figure 45: North America ELISA Analyzers Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 46: North America ELISA Analyzers Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031
Figure 47: North America ELISA Analyzers Market Value (US$ Mn) Share Analysis, by Application, 2022
Figure 48: North America ELISA Analyzers Market Attractiveness Analysis, by Application, 2023–2031
Figure 49: North America ELISA Analyzers Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
Figure 50: North America ELISA Analyzers Market Value (US$ Mn) Share Analysis, by End-user, 2022
Figure 51: North America ELISA Analyzers Market Attractiveness Analysis, by End-user, 2023–2031
Figure 52: Europe ELISA Analyzers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 53: Europe ELISA Analyzers Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 54: Europe ELISA Analyzers Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 55: Europe ELISA Analyzers Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
Figure 56: Europe ELISA Analyzers Market Value (US$ Mn) Share Analysis, by Product Type, 2022
Figure 57: Europe ELISA Analyzers Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 58: Europe ELISA Analyzers Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031
Figure 59: Europe ELISA Analyzers Market Value (US$ Mn) Share Analysis, by Application, 2022
Figure 60: Europe ELISA Analyzers Market Attractiveness Analysis, by Application, 2023–2031
Figure 61: Europe ELISA Analyzers Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
Figure 62: Europe ELISA Analyzers Market Value (US$ Mn) Share Analysis, by End-user, 2022
Figure 63: Europe ELISA Analyzers Market Attractiveness Analysis, by End-user, 2023–2031
Figure 64: Asia Pacific ELISA Analyzers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 65: Asia Pacific ELISA Analyzers Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 66: Asia Pacific ELISA Analyzers Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 67: Asia Pacific ELISA Analyzers Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
Figure 68: Asia Pacific ELISA Analyzers Market Value (US$ Mn) Share Analysis, by Product Type, 2022
Figure 69: Asia Pacific ELISA Analyzers Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 70: Asia Pacific ELISA Analyzers Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031
Figure 71: Asia Pacific ELISA Analyzers Market Value (US$ Mn) Share Analysis, by Application, 2022
Figure 72: Asia Pacific ELISA Analyzers Market Attractiveness Analysis, by Application, 2023–2031
Figure 73: Asia Pacific ELISA Analyzers Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
Figure 74: Asia Pacific ELISA Analyzers Market Value (US$ Mn) Share Analysis, by End-user, 2022
Figure 75: Asia Pacific ELISA Analyzers Market Attractiveness Analysis, by End-user, 2023–2031
Figure 76: Latin America ELISA Analyzers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 77: Latin America ELISA Analyzers Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 78: Latin America ELISA Analyzers Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 79: Latin America ELISA Analyzers Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
Figure 80: Latin America ELISA Analyzers Market Value (US$ Mn) Share Analysis, by Product Type, 2022
Figure 81: Latin America ELISA Analyzers Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 82: Latin America ELISA Analyzers Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031
Figure 83: Latin America ELISA Analyzers Market Value (US$ Mn) Share Analysis, by Application, 2022
Figure 84: Latin America ELISA Analyzers Market Attractiveness Analysis, by Application, 2023–2031
Figure 85: Latin America ELISA Analyzers Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
Figure 86: Latin America ELISA Analyzers Market Value (US$ Mn) Share Analysis, by End-user, 2022
Figure 87: Latin America ELISA Analyzers Market Attractiveness Analysis, by End-user, 2023–2031
Figure 88 Middle East & Africa ELISA Analyzers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 89: Middle East & Africa ELISA Analyzers Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 90: Middle East & Africa ELISA Analyzers Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 91: Middle East & Africa ELISA Analyzers Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
Figure 92: Middle East & Africa ELISA Analyzers Market Value (US$ Mn) Share Analysis, by Product Type, 2022
Figure 93: Middle East & Africa ELISA Analyzers Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 94: Middle East & Africa ELISA Analyzers Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031
Figure 95: Middle East & Africa ELISA Analyzers Market Attractiveness Analysis, by Application, 2023–2031
Figure 96: Middle East & Africa ELISA Analyzers Market Value (US$ Mn) Share Analysis, by Application, 2022
Figure 97: Middle East & Africa ELISA Analyzers Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
Figure 98: Middle East & Africa ELISA Analyzers Market Attractiveness Analysis, by End-user, 2023–2031
Figure 99: Middle East & Africa ELISA Analyzers Market Value (US$ Mn) Share Analysis, by End-user, 2022
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
ELISA Analyzers Market
*86 figures and 60 tables includes